Warfarin and fibrinolysis - a challenging combination: an observational cohort study

BACKGROUND: Patients presenting with ST-segment elevation myocardial infarction (STEMI) frequently use warfarin. Fibrinolytic agents and warfarin both increase bleeding risk, but only a few studies have been published concerning the bleeding risk of warfarin-prescribed patients receiving fibrinolysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saarinen, Sini, Puolakka, Jyrki, Boyd, James, Väyrynen, Taneli, Luurila, Harri, Kuisma, Markku
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080327/
https://www.ncbi.nlm.nih.gov/pubmed/21466702
http://dx.doi.org/10.1186/1757-7241-19-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080327/
https://www.ncbi.nlm.nih.gov/pubmed/21466702
http://dx.doi.org/10.1186/1757-7241-19-21

Ejemplares similares